HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumiyuki Kiuchi Selected Research

komaroviquinone

11/2018A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress.
10/2017Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma.
1/2003New icetexane and 20 norabietane diterpenes with trypanocidal activity from Dracocephalum komarovi.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumiyuki Kiuchi Research Topics

Disease

4Chagas Disease (American Trypanosomiasis)
01/2022 - 01/2003
4Neoplasms (Cancer)
11/2018 - 01/2012
4Infections
01/2016 - 05/2011
3Inflammation (Inflammations)
06/2018 - 04/2013
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2018 - 04/2013
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2018 - 04/2013
2Hypertension (High Blood Pressure)
06/2018 - 04/2013
2Alveolar echinococcosis
01/2016 - 08/2012
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018
1Leukemia
01/2018
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2018
1Multiple Myeloma
10/2017
1Experimental Melanoma
07/2016
1Asthma (Bronchial Asthma)
10/2015
1Bronchitis
10/2015
1Rheumatic Diseases (Rheumatism)
10/2015
1Schistosomiasis (Bilharziasis)
11/2012
1Gastroenteritis
01/2012
1Melanoma (Melanoma, Malignant)
01/2012
1Neoplasm Metastasis (Metastasis)
01/2012
1Papilloma (Papillomatosis)
04/2008
1Carcinogenesis
04/2008
1Substance-Related Disorders (Drug Abuse)
01/2004

Drug/Important Bio-Agent (IBA)

4OligosaccharidesIBA
01/2016 - 05/2011
3Biological ProductsIBA
11/2018 - 11/2016
3komaroviquinoneIBA
11/2018 - 01/2003
3Pharmaceutical PreparationsIBA
01/2018 - 01/2012
2PoisonsIBA
06/2018 - 04/2013
1Antiparasitic Agents (Antiparasitics)IBA
01/2022
1taxodioneIBA
01/2018
1quinone methideIBA
01/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2018
1bcr-abl Fusion ProteinsIBA
01/2018
1DiterpenesIBA
01/2018
1Thalidomide (Thalomid)FDA Link
10/2017
1Histone Deacetylase InhibitorsIBA
10/2017
1Proteasome InhibitorsIBA
10/2017
1FlavonoidsIBA
11/2016
11-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA
07/2016
1zuonin AIBA
07/2016
1GlycosphingolipidsIBA
11/2012
1Proteins (Proteins, Gene)FDA Link
08/2012
1AntigensIBA
08/2012
1CarbohydratesIBA
08/2012
1Morphine (MS Contin)FDA LinkGeneric
02/2012
1OpiumIBA
02/2012
1ThebaineIBA
02/2012
1AlkaloidsIBA
02/2012
1Fibronectins (Fibronectin)IBA
01/2012
1BerberineIBA
01/2012
1I(3)SO3-galactosylceramideIBA
01/2012
1Sulfoglycosphingolipids (Sulfatides)IBA
01/2012
1isosalipurposideIBA
04/2008
1citral (neral)IBA
01/2005
1cannabidiolic acidIBA
01/2004
1AcidsIBA
01/2004

Therapy/Procedure

2Kampo Medicine (Kampo)
06/2018 - 04/2013
1Intraperitoneal Injections
11/2018
1Traditional Medicine (Folk Remedies)
10/2015